Uni-Bio Science Group Limited (HKG:0690)
Hong Kong · Delayed Price · Currency is HKD
0.1100
+0.0020 (1.85%)
At close: Mar 6, 2026
Revenue by Segment
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
|---|
Chemical Pharmaceutical Products | 249.62M | 257.87M | 232.49M | 146.67M | 40.31M | | | | | |
Chemical Pharmaceutical Products Growth | -3.20% | 10.91% | 58.52% | 263.89% | -21.08% | | | | | |
Biological Pharmaceutical Products | 303.36M | 226.85M | 207.82M | 206.74M | 168.47M | | | | | |
Biological Pharmaceutical Products Growth | 33.73% | 9.16% | 0.52% | 22.71% | 6.37% | | | | | |
| 552.98M | 484.72M | 440.32M | 353.41M | 208.78M | | | | | |
| 14.08% | 10.08% | 24.59% | 69.27% | -0.32% | | | | | |
Revenue by Geography
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
|---|
The People's Republic of China (PRC) | 552.98M | 484.72M | 440.32M | 353.41M | 208.78M | | | | | |
The People's Republic of China (PRC) Growth | 14.08% | 10.08% | 24.59% | 69.27% | -0.32% | | | | | |
| 552.98M | 484.72M | 440.32M | 353.41M | 208.78M | | | | | |
| 14.08% | 10.08% | 24.59% | 69.27% | -0.32% | | | | | |
Source: S&P Global Market Intelligence.
